Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 174   

Articles published

GSK 1,415.00 +2.00 (0.14%)
price chart
3 Reasons Why GlaxoSmithKline plc Is The Buy Of 2014!
After a stunning 2013, many UK investors have been surprised at the 1% gains made by the FTSE 100 so far in 2014. However, even that compares very favourably to the performance of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) year-to-date, with the ...
Jefferies Group Reiterates �Hold� Rating for GlaxoSmithKline plc (GSK)
Jefferies Group reiterated their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report sent to investors on Tuesday morning.
3 Reasons Why GlaxoSmithKline plc Could Shoot The Lights Out
Life as a GlaxoSmithKline (LSE: GSK) shareholder has been rather uncomfortable during 2014. That's because the company continues to be embroiled in bribery allegations that are causing sentiment to weaken and, as a result, its shares are taking a ...
Related articles »  
Is Vernalis plc The Perfect Partner For GlaxoSmithKline plc In Your Portfolio?
Of course, Vernalis remains unprofitable but, as today's hugely positive news flow shows, it could prove to be a strong performer moving forward.
Related articles »  
Recent Investment Analysts' Ratings Updates for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc was upgraded by analysts at Goldman Sachs to a �buy� rating. They now have a GBX 1,670 ($27.13) price target on the stock, down previously from GBX 1,700 ($27.62).
Analysts Raise GlaxoSmithKline's Expected TP to N76
�GSK has reported a material decline in EBIT in 1H14, but this is predominantly due to the sale of Lucozade and Ribena by GlaxoSmithKline Plc (not covered) to Suntory (not covered) and the imposition of a licence fee as a result. However, this is ...
Is GlaxoSmithKline plc's Opportunity AstraZeneca plc's Threat?
There are no two better examples of this fact than the case of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and AstraZeneca (LSE: AZN) (NYSE: AZN.
Why You Should Let GlaxoSmithKline plc Look After Your Money
One such company is GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). In the middle of last year, Chinese authorities announced that in recent years GlaxoSmithKline used hundreds of travel agencies and consulting firms to funnel nearly three billion yuan in ...
Related articles »  
GlaxoSmithKline plc Upgraded at Goldman Sachs (GSK)
GlaxoSmithKline plc logo Goldman Sachs upgraded shares of GlaxoSmithKline plc (LON:GSK) to a buy rating in a report issued on Monday.
GlaxoSmithKline plc Earns Underperform Rating from Credit Suisse (GSK)  Ticker Report
GlaxoSmithKline plc Given Consensus Recommendation of "Hold" by ...  sleekmoney
Related articles »  
Are AstraZeneca plc & GlaxoSmithKline plc A Sound Investment Right Now?
Glaxo stock has performed relatively well in the last few weeks, but it appears evident that investors aren't convinced about the company's prospects.
Related articles »